Authors

• Yunpeng Liu (ORCID: https://orcid.org/0000-0003-3306-2470)
• Rachel E. Sanborn (ORCID: https://orcid.org/0000-0003-0542-6054)
• Elliot Chartash (ORCID: https://orcid.org/0000-0002-4836-2372)
• Zev A. Wainberg (ORCID: https://orcid.org/0000-0002-7142-1246)
• Junyou Ge (ORCID: https://orcid.org/0000-0002-6524-0078)
• Alexander I. Spira (ORCID: https://orcid.org/0000-0003-1303-0447)
• Xinhong Wu (ORCID: https://orcid.org/0000-0003-3536-0623)
• Weihong Zhao
• Susanna Varkey Ulahannan (ORCID: https://orcid.org/0000-0002-7234-2283)
• Yan Liang (ORCID: https://orcid.org/0000-0001-9747-4357)
• Omobolaji O. Akala
• Ying Cheng (ORCID: https://orcid.org/0000-0001-9908-597X)
• Guohua Yu (ORCID: https://orcid.org/0000-0002-3260-3178)
• Yongmei Yin (ORCID: https://orcid.org/0000-0003-3335-369X)
• Gesha Liu
• Min Yan (ORCID: https://orcid.org/0000-0002-5184-9210)
• Judy S. Wang
• Ying Wang
• Qun Li (ORCID: https://orcid.org/0000-0002-9128-5405)
• Cuizhi Geng (ORCID: https://orcid.org/0000-0001-5541-5412)
• Yaling Li (ORCID: https://orcid.org/0000-0001-9136-4990)
• Quchang Ouyang (ORCID: https://orcid.org/0000-0003-1233-6081)
• Manish Sharma (ORCID: https://orcid.org/0000-0002-6711-1552)
• Xian Wang (ORCID: https://orcid.org/0000-0002-0652-6498)
• Zhongsheng Tong
• Jordi Rodon (ORCID: https://orcid.org/0000-0002-1032-9091)
• Xiang Wang
• Lihua Song (ORCID: https://orcid.org/0000-0003-2835-0099)

Institutions

• Hebei Medical University (CN)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Van Andel Institute (US)
• The University of Texas MD Anderson Cancer Center (US)
• Sun Yat-sen University (CN)
• University of California, Los Angeles (US)
• Providence Portland Medical Center (US)
• Sir Run Run Shaw Hospital (CN)
• Tianjin Medical University Cancer Institute and Hospital (CN)
• Chinese PLA General Hospital (CN)
• Zhengzhou University (CN)
• Sun Yat-sen Memorial Hospital (CN)
• Jilin Province Tumor Hospital (CN)
• Sarah Cannon (US)
• Shandong Tumor Hospital (CN)
• Fourth Hospital of Hebei Medical University (CN)
• Weifang People's Hospital (CN)
• Hunan Cancer Hospital (CN)
• Virginia Cancer Specialists (US)
• Kelun Group (China) (CN)
• Shanghai East Hospital (CN)
• Oklahoma State University Oklahoma City (US)
• Xuzhou Central Hospital (CN)
• First Hospital of China Medical University (CN)
• Henan Cancer Hospital (CN)
• Jiangsu Province Hospital (CN)
• Hubei Cancer Hospital (CN)
• Shandong First Medical University (CN)
• Zhejiang University (CN)
• China Medical University (CN)

Publication Details

Journal

Journal of Hematology & Oncology

Published

2025-06-06

DOI

https://doi.org/10.1186/s13045-025-01705-2

Citations

10

Primary Topic

Cancer therapeutics and mechanisms

Type

article

Field-Weighted Citation Impact

8.06

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Gilead Sciences
• Array BioPharma
• Regeneron Pharmaceuticals
• Jazz Pharmaceuticals
• Astex Pharmaceuticals
• LAM Therapeutics
• Tizona Therapeutics
• Mersana Therapeutics
• Mirati Therapeutics
• BeiGene
• Incyte
• Revolution Medicines
• Moderna
• MacroGenics
• G1 Therapeutics
• Seagen
• Astellas Pharma
• Symphogen
• Plexxikon
• Ignyta
• Loxo Oncology
• Daiichi Sankyo Europe